UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

FAST: a randomised phase II study of zolbetuximab (IMAB362) plus EOX versus EOX alone for first-line treatment of advanced CLDN18.2-positive gastric and gastro-oesophageal adenocarcinoma

Annals of oncology, 2021-05, Vol.32 (5), p.609-619

2021

Volltextzugriff (PDF)

A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus: the MONO study

Annals of oncology, 2019-09, Vol.30 (9), p.1487-1495

2019

Volltextzugriff (PDF)

Two distinct functional effects of protein phosphatase inhibitors on guinea-pig cardiac L-type Ca2+ channels

The Journal of physiology, 1995-05, Vol.484 (Pt 3), p.583-592

1995

Volltextzugriff (PDF)

Caveolin-1 Is Down-Regulated in Human Ovarian Carcinoma and Acts as a Candidate Tumor Suppressor Gene

The American journal of pathology, 2001-11, Vol.159 (5), p.1635-1643

2001

Volltextzugriff (PDF)

Down-Regulation of Caveolin-1, a Candidate Tumor Suppressor Gene, in Sarcomas

The American journal of pathology, 2001-03, Vol.158 (3), p.833-839

2001

Volltextzugriff (PDF)

Suppression of the c-erbB-2 gene product decreases transformation abilities but not the proliferation and secretion of proteases of SK-OV-3 ovarian cancer cells

British Journal of Cancer, 1999-11, Vol.81 (5), p.790-795

1999

Volltextzugriff (PDF)

Diagnostic difficulties before definitive treatment of an extragonadal retroperitoneal germ cell tumor

Urology (Ridgewood, N.J.), 2001-08, Vol.58 (2), p.281-281

2001

Volltextzugriff (PDF)

Loss of Gelsolin expression in human ovarian carcinomas

European journal of cancer (1990), 2005-02, Vol.41 (3), p.461-469

2005

Volltextzugriff (PDF)

Biochemical and electrophysiological mechanisms of the positive inotropic effect of calyculin A, a protein phosphatase inhibitor

The Journal of pharmacology and experimental therapeutics, 1994-10, Vol.271 (1), p.535

1994

Volltextzugriff (PDF)

Discordant results obtained for different methods of HER-2/neu testing in breast cancer: a question of standardization, automation and timing

The International journal of biological markers, 2004, Vol.19 (1), p.1-13

2004

Volltextzugriff (PDF)

Systematic identification and molecular characterization of genes differentially expressed in breast and ovarian cancer

The Journal of pathology, 2005-01, Vol.205 (1), p.21-28

2005

Volltextzugriff (PDF)

A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus: the MONO study

Annals of oncology, 2019-09, Vol.30 (9), p.1487

2019

Volltextzugriff (PDF)

The class II tumour suppressor gene H-REV107-1 is a target of interferon-regulatory factor-1 and is involved in IFNγ-induced cell death in human ovarian carcinoma cells

Oncogene, 2002-04, Vol.21 (18), p.2829-2839

2002

Volltextzugriff (PDF)

Antisense phosphorothioate oligodeoxynucleotide down‐regulation of the insulin‐like growth factor I receptor in ovarian cancer cells

International journal of cancer, 1998-08, Vol.77 (4), p.567-571

1998

Volltextzugriff (PDF)

Formalin-fixed blood clots--additional histological findings on computed tomography-guided fine-needle aspiration biopsies in comparison with core biopsies

Journal of computer assisted tomography, 2006-05, Vol.30 (3), p.386-390

2006

Volltextzugriff (PDF)

Selection of a high activity c-erbB-2 ribozyme using a fusion gene of c-erbB-2 and the enhanced green fluorescent protein

Cancer gene therapy, 1998-01, Vol.5 (1), p.45-51

1998

Volltextzugriff (PDF)

Involvement of the c‐erbB‐2 oncogene product in the egf‐induced cell motility of sk‐ov‐3 ovarian cancer cells

International journal of cancer, 1999-10, Vol.83 (3), p.409-414

1999

Volltextzugriff (PDF)

The class II tumour suppressor gene H-REV107-1 is a target of interferon-regulatory factor-1 and is involved in IFN gamma -induced cell death in human ovarian carcinoma cells

Oncogene, 2002-04, Vol.21 (18), p.2829-2839

2002

Volltextzugriff (PDF)

Discordant results obtained for different methods of HER-2/neu testing in breast cancer a question of standardization, automation and timing

The International journal of biological markers, 2004, Vol.19 (1), p.1-13

2004

Volltextzugriff (PDF)

c‐erbB‐2 anti‐sense phosphorothioate oligodeoxynucleotides inhibit growth and serum‐induced cell spreading of p185c‐erbB‐2‐overexpressing ovarian carcinoma cells

International journal of cancer, 1995-11, Vol.63 (4), p.604-608

1995

Volltextzugriff (PDF)

Isoelektrische Fokussierung von Fruchtwasser-AFP zur Diagnose offener Neuralrohrdefekte

Archives of gynecology and obstetrics, 1993-12, Vol.254 (1-4), p.38-39

1993

Volltextzugriff (PDF)

Expression of gelsolin in ovarian carcinomas

Pathology, research and practice, 2004, Vol.200 (4), p.294-294

2004

Volltextzugriff (PDF)

Isoelectric focusing of amniotic fluid α-fetoprotein to improve diagnosis of neural tube defects

The Lancet (British edition), 1991-03, Vol.337 (8742), p.674-674

1991

Volltextzugriff (PDF)

Isoelectric focusing patterns of human anmiotic fluid α-fetoprotein

Prenatal diagnosis, 1991, Vol.11 (7), p.427-435

1991

Volltextzugriff (PDF)

Isoelectric focusing pattern of human amniotic fluid α-fetoprotein

Prenatal diagnosis, 1991-07, Vol.11 (7), p.427-435

1991

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(45)
Buchkapitel
(2)

Sprache

Englisch
(43)
Deutsch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

FAST: a randomised phase II study of zolbetuximab (IMAB362) plus EOX versus EOX alone for first-line treatment of advanced CLDN18.2-positive gastric and gastro-oesophageal adenocarcinoma

A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus: the MONO study

Two distinct functional effects of protein phosphatase inhibitors on guinea-pig cardiac L-type Ca2+ channels

Caveolin-1 Is Down-Regulated in Human Ovarian Carcinoma and Acts as a Candidate Tumor Suppressor Gene

Down-Regulation of Caveolin-1, a Candidate Tumor Suppressor Gene, in Sarcomas

Suppression of the c-erbB-2 gene product decreases transformation abilities but not the proliferation and secretion of proteases of SK-OV-3 ovarian cancer cells

Diagnostic difficulties before definitive treatment of an extragonadal retroperitoneal germ cell tumor

Loss of Gelsolin expression in human ovarian carcinomas

Biochemical and electrophysiological mechanisms of the positive inotropic effect of calyculin A, a protein phosphatase inhibitor

Discordant results obtained for different methods of HER-2/neu testing in breast cancer: a question of standardization, automation and timing

Systematic identification and molecular characterization of genes differentially expressed in breast and ovarian cancer

A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus: the MONO study

The class II tumour suppressor gene H-REV107-1 is a target of interferon-regulatory factor-1 and is involved in IFNγ-induced cell death in human ovarian carcinoma cells

Antisense phosphorothioate oligodeoxynucleotide down‐regulation of the insulin‐like growth factor I receptor in ovarian cancer cells

Formalin-fixed blood clots--additional histological findings on computed tomography-guided fine-needle aspiration biopsies in comparison with core biopsies

Selection of a high activity c-erbB-2 ribozyme using a fusion gene of c-erbB-2 and the enhanced green fluorescent protein

Involvement of the c‐erbB‐2 oncogene product in the egf‐induced cell motility of sk‐ov‐3 ovarian cancer cells

The class II tumour suppressor gene H-REV107-1 is a target of interferon-regulatory factor-1 and is involved in IFN gamma -induced cell death in human ovarian carcinoma cells

Discordant results obtained for different methods of HER-2/neu testing in breast cancer a question of standardization, automation and timing

c‐erbB‐2 anti‐sense phosphorothioate oligodeoxynucleotides inhibit growth and serum‐induced cell spreading of p185c‐erbB‐2‐overexpressing ovarian carcinoma cells

Isoelektrische Fokussierung von Fruchtwasser-AFP zur Diagnose offener Neuralrohrdefekte

Expression of gelsolin in ovarian carcinomas

Isoelectric focusing of amniotic fluid α-fetoprotein to improve diagnosis of neural tube defects

Isoelectric focusing patterns of human anmiotic fluid α-fetoprotein

Isoelectric focusing pattern of human amniotic fluid α-fetoprotein

Suchergebnisse filtern